House dust mite sublingual allergen immunotherapy tablet is safe and well-tolerated in Dutch clinical practice

House dust mite sublingual allergen immunotherapy tablet is safe and well-tolerated in Dutch clinical practice

BackgroundHalf (49%) of clinically diagnosed allergic rhinitis (AR) patients are sensitized to house dust mite (HDM). If allergen avoidance and symptomatic medication fail, allergen immunotherapy may be indicated.ObjectiveWe investigated safety and tolerability of HDM-sublingual immunotherapy by HDM...

Full description

Bibliographic Details
Main Authors: Žana Tempels-Pavlica, Mark C. J. Aarts, Paco M. J. Welsing, Akke-Nynke van der Meer, Leonard P. van der Zwan, Elena Uss, André C. Knulst
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Allergy
Subjects:
allergic rhinitis
Control of Allergic Rhinitis and Asthma Test (CARAT)
house dust mite (HDM)
safety
sublingual immunotherapy tablet
non-interventional study
Online Access:https://www.frontiersin.org/articles/10.3389/falgy.2024.1355324/full

Internet

https://www.frontiersin.org/articles/10.3389/falgy.2024.1355324/full

Similar Items